Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

@article{Bonnet2007EfficacyOA,
  title={Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Z{\'e}r{\'e}kor{\'e}},
  author={Maryline M B Bonnet and Cally Roper and Martine F{\'e}lix and L{\'e}onie Coulibaly and Gabriel Mufuta Kankolongo and Jean Paul Guthmann},
  journal={Malaria Journal},
  year={2007},
  volume={6},
  pages={54 - 54}
}
In the last five years, countries have been faced with changing their malaria treatment policy to an artemisinin-based combination therapy (ACT), many with no national data on which to base their decision. This is particularly true for a number of West African countries, including Guinea, where these studies were performed. Two studies were conducted in 2004/2005 in programmes supported by Medecins Sans Frontieres, when chloroquine was still national policy, but artesunate (AS)/sulphadoxine… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 14 references

Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia.

Transactions of the Royal Society of Tropical Medicine and Hygiene • 2002
View 5 Excerpts

Similar Papers

Loading similar papers…